Trials / Completed
CompletedNCT04172701
A Study in South Korea Using Medical Records to Look at Different Treatments for Chronic Obstructive Airway Disease (COPD)
CITRUS Study (Comparing the Incidence Between Tiotropium and ICS/LABA in Real World Use in South Korea)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 9,284 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Not accepted
Summary
Non-interventional, Single-country study based on existing data from medical records of COPD patients treated with LAMA or fixed dose combination of ICS/LABA
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Long-acting Muscarinic Antagonists (LAMA) | drug |
| DRUG | Inhaled corticosteroid (ICS)/Long-acting Beta Agonists (LABA) | drug |
Timeline
- Start date
- 2020-04-15
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2019-11-21
- Last updated
- 2022-04-07
- Results posted
- 2022-04-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04172701. Inclusion in this directory is not an endorsement.